Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Rizzo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Breast Cancer Research and Treatment|March 19, 2020
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scannerGiovanna Panzironi, Giuliana Moffa, Francesca Galati, et al.
Frontiers in Oncology|May 21, 2021
Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRIVeronica Rizzo, Giuliana Moffa, Endi Kripa, et al.
BJR Open|September 15, 2022
MRI as a biomarker for breast cancer diagnosis and prognosisFrancesca Galati, Veronica Rizzo, Rubina Manuela Trimboli, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?Francesca Galati, Valentina Magri, Giuliana Moffa, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 10, 2024
Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?Veronica Rizzo, Federica Cicciarelli, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|August 12, 2023
Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense BreastsGiuliana Moffa, Francesca Galati, Roberto Maroncelli, et al.
Diagnostics (Basel, Switzerland)|December 18, 2020
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?Giuliana Moffa, Francesca Galati, Emmanuel Collalunga, et al.
Frontiers in Oncology|October 10, 2022
Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesityEndi Kripa, Veronica Rizzo, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological-Pathological ComparisonFederica Cicciarelli, Elisa Guiducci, Francesca Galati, et al.
La Radiologia Medica|November 13, 2024
BPE on contrast-enhanced mammography: relationship with breast density, age and menopausal statusGiuliana Moffa, Francesca Galati, Alessandra Spagnoli, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|March 19, 2020
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scannerGiovanna Panzironi, Giuliana Moffa, Francesca Galati, et al.
Frontiers in Oncology|May 21, 2021
Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRIVeronica Rizzo, Giuliana Moffa, Endi Kripa, et al.
BJR Open|September 15, 2022
MRI as a biomarker for breast cancer diagnosis and prognosisFrancesca Galati, Veronica Rizzo, Rubina Manuela Trimboli, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?Francesca Galati, Valentina Magri, Giuliana Moffa, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 10, 2024
Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?Veronica Rizzo, Federica Cicciarelli, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|August 12, 2023
Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense BreastsGiuliana Moffa, Francesca Galati, Roberto Maroncelli, et al.
Diagnostics (Basel, Switzerland)|December 18, 2020
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?Giuliana Moffa, Francesca Galati, Emmanuel Collalunga, et al.
Frontiers in Oncology|October 10, 2022
Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesityEndi Kripa, Veronica Rizzo, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological-Pathological ComparisonFederica Cicciarelli, Elisa Guiducci, Francesca Galati, et al.
La Radiologia Medica|November 13, 2024
BPE on contrast-enhanced mammography: relationship with breast density, age and menopausal statusGiuliana Moffa, Francesca Galati, Alessandra Spagnoli, et al.
Pageof 3